// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Outcomes reported in pneumonia randomized controlled trials

Alexander Mathioudakis - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Hospital aquired pneumonia- what’s the score? A scoping & observational study on severity scoring indicies in HAP

Michael Peirson - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Covid Oximetry AT Home - A novel pandemic approach

Malapanjudi Chandrashekar - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Acute lung injury

N/A

Admission clinical parameters in predicting in-hospital mortality in COVID-19

Dalia Mudawi - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

The use of pharmacological therapies in hospitalized COVID-19 patients– A literature review

Eileen Han - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Rapid diagnosis of bacterial co-infection and antimicrobial resistance in patients with SARS-Cov-2 infection

Hollian Richardson - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Elevated NETosis and migration but impaired anti-microbial responses by COVID-19 neutrophils

Kylie Belchamber - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Resolution of radiological changes on follow up chest x-ray at 6 to 12 weeks post Covid pneumonitis in a UK district general hospital

Asad Anwar - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Pulmonary alveolar proteinosis

N/A

Management of COVID-19 pneumonia in an enhanced respiratory step down unit: a novel approach

Vishal Amrish Agrawal - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Severe COVID-19 pneumonia

N/A

Economic burden of pertussis among adults 50 years and above: a retrospective observational study in England

Lauriane Harrington - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Pertussis

N/A

Sputum neutrophil elastase and inhaled antibiotic response in bronchiectasis: a post-hoc analysis of the ORBIT-4 trial

Hani Abo-Leyah - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Ciprofloxacin

Changes in sputum bacterial density in people with bronchiectasis: BRONCH UK Study data

Zina Alfahl - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The bronchiectasis ‘bacteriophagome’

Micheál Mac Aogáin - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Characterisation of eosinophilic bronchiectasis: A European multicohort study

Amelia Shoemark - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Inhaled corticosteroids use in patients with bronchiectasis: Data from the EMBARC registry

Eva Polverino - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Long term clinical outcomes of bronchiectasis in India: Data from the EMBARC/RRNI Indian Bronchiectasis Registry

Raja Dhar - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

External assessment and validation of the RAPID score using an international multicentre pleural infection cohort treated with intrapleural fibrinolytics

Eihab Bedawi - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Functional profiling and visualization of stromal cell dynamics in the influenza virus infected lung

Worrell Julie - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Influenza

N/A

Deteriorating heath status in bronchiectasis : longitudinal data from the EMBARC registry

Stefano Aliberti - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Quality of care in bronchiectasis using the European Respiratory Society Guidelines as a reference standard- data from the EMBARC registry

Pieter Goeminne - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved